184 related articles for article (PubMed ID: 27966803)
1. Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.
Spewak MB; Williamson RS; Mertens AC; Border WL; Meacham LR; Wasilewski-Masker KJ
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27966803
[TBL] [Abstract][Full Text] [Related]
2. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
3. Echocardiographic Detection of Cardiac Dysfunction in Childhood Cancer Survivors: How Long Is Screening Required?
Ramjaun A; AlDuhaiby E; Ahmed S; Wang L; Yu E; Nathan PC; Hodgson DC
Pediatr Blood Cancer; 2015 Dec; 62(12):2197-203. PubMed ID: 26146944
[TBL] [Abstract][Full Text] [Related]
4. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
[TBL] [Abstract][Full Text] [Related]
5. Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H; Nielsen G
Pediatr Blood Cancer; 2010 Mar; 54(3):444-8. PubMed ID: 19830828
[TBL] [Abstract][Full Text] [Related]
6. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study.
van der Pal HJ; van Dijk IW; Geskus RB; Kok WE; Koolen M; Sieswerda E; Oldenburger F; Koning CC; van Leeuwen FE; Caron HN; Kremer LC; van Dalen EC
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):213-22. PubMed ID: 25442333
[TBL] [Abstract][Full Text] [Related]
7. Utility of Echocardiography as Screening for Late-onset Anthracycline-induced Cardiotoxicity in Pediatric Cancer Survivors: Observations from the First Decade After End of Therapy.
Moke DJ; Schubert LE; Sun HY; Printz BF; Dietz AC
J Pediatr Hematol Oncol; 2018 Jul; 40(5):e283-e288. PubMed ID: 29432303
[TBL] [Abstract][Full Text] [Related]
8. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors.
Hudson MM; Rai SN; Nunez C; Merchant TE; Marina NM; Zalamea N; Cox C; Phipps S; Pompeu R; Rosenthal D
J Clin Oncol; 2007 Aug; 25(24):3635-43. PubMed ID: 17704413
[TBL] [Abstract][Full Text] [Related]
10. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines?
Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-associated cardiomyopathy in survivors of childhood cancer.
Hines MR; Mulrooney DA; Hudson MM; Ness KK; Green DM; Howard SC; Krasin M; Metzger ML
J Cancer Surviv; 2016 Feb; 10(1):113-21. PubMed ID: 26044903
[TBL] [Abstract][Full Text] [Related]
12. Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation.
Rotz SJ; Powell A; Myers KC; Taylor MD; Jefferies JL; Lane A; El-Bietar JA; Davies SM; Dandoy CE; Ryan TD
Cardiol Young; 2019 Mar; 29(3):338-343. PubMed ID: 30744727
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.
Mulrooney DA; Armstrong GT; Huang S; Ness KK; Ehrhardt MJ; Joshi VM; Plana JC; Soliman EZ; Green DM; Srivastava D; Santucci A; Krasin MJ; Robison LL; Hudson MM
Ann Intern Med; 2016 Jan; 164(2):93-101. PubMed ID: 26747086
[TBL] [Abstract][Full Text] [Related]
14. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
[TBL] [Abstract][Full Text] [Related]
15. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
16. Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity.
Feijen EAM; Leisenring WM; Stratton KL; Ness KK; van der Pal HJH; van Dalen EC; Armstrong GT; Aune GJ; Green DM; Hudson MM; Loonen J; Oeffinger KC; Robison LL; Yasui Y; Kremer LCM; Chow EJ
JAMA Oncol; 2019 Jun; 5(6):864-871. PubMed ID: 30703192
[TBL] [Abstract][Full Text] [Related]
17. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
18. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
Andolina JR; Dilley K
J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center.
Watts RG; George M; Johnson WH
Cancer; 2012 Apr; 118(7):1919-24. PubMed ID: 21882180
[TBL] [Abstract][Full Text] [Related]
20. Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM; Dreyer ZE; Hudson MM; Robison LL; Blanco JG; Relling MV; Burridge P; Bhatia S
Cancer; 2020 Sep; 126(17):4051-4058. PubMed ID: 32413235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]